ABUS icon

Arbutus Biopharma

53 hedge funds and large institutions have $118M invested in Arbutus Biopharma in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
-2
Holders Change %
-3.64%
% of All Funds
1.32%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
13
Reduced
21
Closed
10
Calls
$106K
Puts
$175K
Net Calls
-$69K
Net Calls Change
+$498K
Name Holding Trade Value Shares
Change
Shares
Change %
IA
51
IFP Advisors
Florida
$1K
SIM
52
Sonora Investment Management
Arizona
$65
DCM
53
DAFNA Capital Management
California
-$573K -234,000 Closed
AFM
54
Anson Funds Management
Texas
-$257K -105,085 Closed
DTL
55
Dynamic Technology Lab
Singapore
-$98K -40,017 Closed
DCM
56
Dialectic Capital Management
Connecticut
-$61K -25,000 Closed
VKH
57
Virtu KCG Holdings
New York
-$58K -23,700 Closed
SFM
58
Sphera Funds Management
Israel
-$54K -22,000 Closed
TC
59
TFS Capital
Pennsylvania
-$35K -14,195 Closed
Squarepoint
60
Squarepoint
New York
-$33K -13,400 Closed
JG
61
Jefferies Group
New York
-$25K -10,300 Closed
Walleye Trading
62
Walleye Trading
New York
-$17K -7,000 Closed